Probing the Influence of Single-Site Mutations in the Central Cross-β Region of Amyloid β (1-40) Peptides

探究淀粉样β肽(1-40)中心交叉β区单点突变的影响

阅读:1

Abstract

Amyloid β (Aβ) is a peptide known to form amyloid fibrils in the brain of patients suffering from Alzheimer's disease. A complete mechanistic understanding how Aβ peptides form neurotoxic assemblies and how they kill neurons has not yet been achieved. Previous analysis of various Aβ(40) mutants could reveal the significant importance of the hydrophobic contact between the residues Phe(19) and Leu(34) for cell toxicity. For some mutations at Phe(19), toxicity was completely abolished. In the current study, we assessed if perturbations introduced by mutations in the direct proximity of the Phe(19)/Leu(34) contact would have similar relevance for the fibrillation kinetics, structure, dynamics and toxicity of the Aβ assemblies. To this end, we rationally modified positions Phe(20) or Gly(33). A small library of Aβ(40) peptides with Phe(20) mutated to Lys, Tyr or the non-proteinogenic cyclohexylalanine (Cha) or Gly(33) mutated to Ala was synthesized. We used electron microscopy, circular dichroism, X-ray diffraction, solid-state NMR spectroscopy, ThT fluorescence and MTT cell toxicity assays to comprehensively investigate the physicochemical properties of the Aβ fibrils formed by the modified peptides as well as toxicity to a neuronal cell line. Single mutations of either Phe(20) or Gly(33) led to relatively drastic alterations in the Aβ fibrillation kinetics but left the global, as well as the local structure, of the fibrils largely unchanged. Furthermore, the introduced perturbations caused a severe decrease or loss of cell toxicity compared to wildtype Aβ(40). We suggest that perturbations at position Phe(20) and Gly(33) affect the fibrillation pathway of Aβ(40) and, thereby, influence the especially toxic oligomeric species manifesting so that the region around the Phe(19)/Leu(34) hydrophobic contact provides a promising site for the design of small molecules interfering with the Aβ fibrillation pathway.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。